Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00355589 · ClinicalTrials.gov registry record · Phase 3
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00355589 is a Phase 3 study that has completed, run by Pfizer.
The verdict
NCT00355589, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to determine if there is greater blood pressure reduction using ramipril or hydrochlorothiazide alone or ramipril and hydrochlorothiazide together.
Interventions
- DRUG Ramipril and hydrochlorothiazide
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-07 |
| Est. Completion | 2007-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00355589
The ClinicalTrials.gov registry entry for NCT00355589 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ramipril and hydrochlorothiazide is the first listed.
NCT00355589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00355589 about?
NCT00355589 is a clinical study titled "Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension". The purpose of this study is to determine if there is greater blood pressure reduction using ramipril or hydrochlorothiazide alone or ramipril and hydrochlorothiazide together.
What is the current status of trial NCT00355589?
This trial is currently completed. It is a Phase 3 study. The study started on 2006-07. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00355589?
The interventions under investigation include: Ramipril and hydrochlorothiazide (DRUG).
Who is sponsoring clinical trial NCT00355589?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.